Kara Hughan, Pediatrics - Pediatric Endocrinology Medicare: Accepting Medicare Assignments Practice Location: 3 Walnut St Ste 205, Lemoyne, PA 17043 Phone: 717-988-0090 |
Bach-mai Vu-boast, Pediatrics - Pediatric Endocrinology Medicare: Accepting Medicare Assignments Practice Location: 3 Walnut St Ste 205, Lemoyne, PA 17043 Phone: 717-988-0090 |
Dr. Rebecca L Smith, MD Pediatrics - Pediatric Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 3 Walnut St Ste 205, Lemoyne, PA 17043 Phone: 717-988-0090 Fax: 717-221-5320 |
Dr. Shira Novack, M.D. Pediatrics - Pediatric Endocrinology Medicare: Medicare Enrolled Practice Location: 3 Walnut St Ste 205, Lemoyne, PA 17043 Phone: 717-988-0090 Fax: 717-221-5320 |
Mrs. Laura Alice Watkins, M.D. Pediatrics - Pediatric Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 3 Walnut St Ste 205, Lemoyne, PA 17043 Phone: 717-988-0090 Fax: 717-221-5320 |
Dale King, Pediatrics - Pediatric Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3 Walnut St Ste 205, Third Floor, Lemoyne, PA 17043 Phone: 717-988-0090 |
Amanda C. Ferguson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3 Walnut St Ste 205, Lemoyne, PA 17043 Phone: 717-988-0090 |
News Archive
Oregon and Utah have waiver requests pending. Meanwhile, in Tennessee, steep Medicaid cuts are leading to the sale of some hospitals. And, in Arizona, a judge will soon decide whether health coverage should be restored for some low-income state residents whose health insurance ceased as a result of budget cuts.
New results from a study by neuroscientists at Rush University Medical Center suggest that people at risk of developing Alzheimer's disease exhibit a specific structural change in the brain that can be visualized by brain imaging. The findings may help identify those who would most benefit from early intervention.
4SC, a drug discovery and development company focused on autoimmune and cancer indications, today announced that it will present four posters and respective abstracts that highlight the development of its lead oncology compound resminostat and several preclinical drug candidates at the 22nd EORTC-NCI-AACR symposium from 16 - 19 November, 2010 in Berlin, Germany.
The team headed by Doctor Manuel Casal, head of Microbiology at Reina Sofia Hospital in Cordoba has validated in patients a technique, originally produced by a German company, capable of diagnosing tuberculosis in only one day and determining whether or not it is resistant to two of the drugs used to treat this disease.
› Verified 8 days ago